Alzheimer's Disease Trial, Recruiting (NCT06448403)

Alzheimer's Disease Trial, Recruiting NCT06448403 Sponsor: Norwegian University of Science and Technology Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06448403 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD), based on recognised medical diagnosis guidelines
For the control group (healthy comparison group): you are a similar age and gender to others in the study

Who may not be able to join:

You are unable to have brain scans using MRI or EEG equipment (for example, if you have a pacemaker or are unable to tolerate these procedures)
You were diagnosed with Alzheimer's disease before the age of 65 (known as early-onset Alzheimer's)
You have a brain tumour
You have had a serious head injury
You have previously had brain surgery
You have another condition affecting the brain or nervous system, such as Parkinson's disease or ALS (motor neurone disease)
You have a condition related to inflammation or the immune system attacking the body, such as Multiple Sclerosis (MS)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

This information is presented for general understanding only and does not constitute medical advice. Only the trial team can confirm whether you or someone you know is eligible to participate.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06448403

Sponsor: Norwegian University of Science and Technology

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT06448403

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD), based on recognised medical diagnosis guidelines
For the control group (healthy comparison group): you are a similar age and gender to others in the study

Who may not be able to join:

You are unable to have brain scans using MRI or EEG equipment (for example, if you have a pacemaker or are unable to tolerate these procedures)
You were diagnosed with Alzheimer's disease before the age of 65 (known as early-onset Alzheimer's)
You have a brain tumour
You have had a serious head injury
You have previously had brain surgery
You have another condition affecting the brain or nervous system, such as Parkinson's disease or ALS (motor neurone disease)
You have a condition related to inflammation or the immune system attacking the body, such as Multiple Sclerosis (MS)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

This information is presented for general understanding only and does not constitute medical advice. Only the trial team can confirm whether you or someone you know is eligible to participate.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Norwegian University of Science and Technology

Registry

ClinicalTrials.gov

Start date

1 July 2024

Est. completion

29 December 2030

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

MCI-AD converters; AD-subclassification

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov